EPI-589, a quinone derivative, is a safe and well tolerated oxidoreductase enzyme inhibitor. EPI-589 has the highly potential for the treatment of amyotrophic lateral sclerosis (ALS). References: [1]. BioElectron’s EPI-589 Shows Positive Results in ALS Patients in Phase 2a Trial [2]. Phase IIa trial of EPI-589 in ALS shows improvement in CSF

纯度：≥98%

CAS：1147883-03-1